Why is SMS Pharma. falling/rising?
As of 28-Jul, SMS Pharmaceuticals Ltd is priced at Rs 238.85, showing a slight increase today after two days of decline. Despite recent short-term challenges, the company has demonstrated strong long-term growth and may be undervalued, presenting a potential buying opportunity.
As of 28-Jul, SMS Pharmaceuticals Ltd is currently priced at Rs 238.85, reflecting an increase of Rs 1.85 or 0.78%. Today, the stock has shown a positive trend, gaining after two consecutive days of decline and outperforming its sector by 0.7%. It reached an intraday high of Rs 242.95, indicating some recovery potential. However, the stock has experienced a decline of 3.46% over the past week and 3.90% over the past month, while its year-to-date performance shows a slight decrease of 0.42%. Despite these short-term challenges, the company has reported positive results for the last nine consecutive quarters, with a significant growth in profit after tax and a strong operating profit to interest ratio, which may support investor confidence.In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has declined by 1.59% over the past week and 3.77% over the past month. While SMS Pharmaceuticals has underperformed the benchmark in the short term, its long-term performance remains robust, with a remarkable 177.25% increase over the past three years and 214.90% over the past five years. The stock is currently trading at a discount compared to its peers' average historical valuations, and despite the recent price fluctuations, the company's profits have risen significantly, suggesting that the stock may be undervalued and could present a buying opportunity for investors looking for growth potential.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
